1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Release of silicone oil droplets from syringes

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Intravitreal silicone oil droplets have been found in the vitreous. The aim of this study is to compare the rates of silicone oil released by different brands of commonly used syringes for intravitreal injection after agitation by flicking.

          Methods

          Three models of two brands of syringes were analyzed for their rates of silicone oil release: Saldanha Rodrigues (SR) 1 mL insulin syringe (SR, Brazil, syringe 1), Becton–Dickinson (BD) Plastipak 1 mL insulin syringe (Brazil, syringe 2), and BD Safety-Glide 1 mL insulin syringe (USA, syringe 3). All syringes were tested under four different conditions: positive control (fluid with addition of silicone oil) without agitation (group 1, n = 5); positive control with agitation (group 2, n = 3); fluid only without agitation (group 3, n = 5); and fluid only with agitation (group 4, n = 5). Masked graders performed all analyses using light microscopy.

          Results

          All syringes (1, 2, and 3) released silicone oil droplets in the positive control group regardless of the agitation status (groups 1 and 2). When no oil was added and the syringes were not agitated, only syringe 1 released silicone oil droplets (40% of samples). After agitation, syringes 1 and 3 released silicone oil droplets in all samples. Quantitative analysis showed a significantly ( P = 0.011; 11.2 ± 2.9 vs. 0.6 ± 0.9, respectively) higher mean number of silicone oil droplets released by syringe 1 after agitation compared to no agitation. Syringe 1 also had significantly ( P = 0.002, 11.2 ± 2.9 vs. 0.0 ± 0.0 vs. 2.2 ± 0.8, respectively) more droplets than syringes 2 and 3 after agitation.

          Conclusions

          Syringes commonly used for intravitreal injections frequently release silicone oil droplets when agitated by flicking, especially the SR insulin ones. We recommend that they not be agitated at the time of intravitreal injection and that the manufacturers consider producing syringes adapted for intraocular use.

          Related collections

          Most cited references19

          • Record: found
          • Abstract: found
          • Article: found

          2018 Update on Intravitreal Injections: Euretina Expert Consensus Recommendations

          Intravitreal injections (IVI) have become the most common intraocular procedure worldwide with increasing numbers every year. The article presents the most up-to-date review on IVI epidemiology and techniques. Unfortunately, important issues related to pre-, peri- and postinjection management lack randomized clinical trials for a final conclusion. Also, a great diversity of approaches exists worldwide. Therefore, expert consensus recommendations on IVI techniques are provided.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Advantages and limitations of small gauge vitrectomy.

            Small gauge vitrectomy utilizing 23- and 25-gauge instrumentation has definite advantages, but also limitations, due to the physics of smaller instruments and sutureless surgery. Higher infusion and aspiration pressures are needed to remove the vitreous using 23- and 25-gauge probes. The advantages include decreased surgical times, less tissue manipulation, reduced inflammation and pain postoperatively with more rapid visual recovery. A disadvantage is greater instrument flexion than 20-gauge probes, making small gauge vitrectomy more appropriate for indications such as vitreous opacities, epiretinal membranes, macular holes, and simple retinal detachments. There are also some increased complications related to small gauge vitrectomy, including dislocation of cannulas intraoperatively, early postoperative hypotony, choroidal detachment, and possibly an increased risk of infectious endophthalmitis.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Anti-VEGF Therapy and the Retina: An Update

              Ocular angiogenesis and macular oedema are major causes of sight loss across the world. Aberrant neovascularisation, which may arise secondary to numerous disease processes, can result in reduced vision as a result of oedema, haemorrhage, and scarring. The development of antivascular endothelial growth factor (anti-VEGF) agents has revolutionised the treatment of retinal vasogenic conditions. These drugs are now commonly employed for the treatment of a plethora of ocular pathologies including choroidal neovascularisation, diabetic macular oedema, and retinal vein occlusion to name a few. In this paper, we will explore the current use of anti-VEGF in a variety of retinal diseases and the impact that these medications have had on visual outcome for patients.
                Bookmark

                Author and article information

                Contributors
                gustavobmelo@yahoo.com.br
                celso_dias@live.com
                marireisc@hotmail.com
                alexandrelc10@hotmail.com
                fabiomoraisoftalmo@gmail.com
                ana.figueira@lnbio.cnpem.br
                acaciolima@gmail.com
                geoffrey.g.emerson@gmail.com
                mmaia@unifesp.br
                Journal
                Int J Retina Vitreous
                Int J Retina Vitreous
                International Journal of Retina and Vitreous
                BioMed Central (London )
                2056-9920
                3 January 2019
                3 January 2019
                2019
                : 5
                : 1
                Affiliations
                [1 ]Hospital de Olhos de Sergipe, Rua Campo do Brito, 995 São José, 49020-380 Aracaju, SE Brazil
                [2 ]ISNI 0000 0001 0514 7202, GRID grid.411249.b, Federal University of São Paulo, ; São Paulo, SP Brazil
                [3 ]ISNI 0000 0004 0445 0877, GRID grid.452567.7, Brazilian Biosciences National Laboratory, , Brazilian Center for Research in Energy and Materials, ; Campinas, SP Brazil
                [4 ]Retina Center of Minnesota, Minneapolis, MN USA
                Article
                153
                10.1186/s40942-018-0153-8
                6318836
                30788149
                092dd7b8-89e5-4695-93a2-a0b640d4e30c
                © The Author(s) 2019

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 2 December 2018
                : 24 December 2018
                Categories
                Original Article
                Custom metadata
                © The Author(s) 2019

                syringe,intravitreal injection,silicone oil droplets

                Comments

                Comment on this article